EP4190359 - SAPONIN-BASED ADJUVANTS AND VACCINES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.04.2024 Database last updated on 03.06.2024 | |
Former | The application has been published Status updated on 05.05.2023 | Most recent event Tooltip | 05.04.2024 | Application deemed to be withdrawn | published on 08.05.2024 [2024/19] | Applicant(s) | For all designated states Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE Parque Tecnológico de Bizkaia Edificio 801, Planta 1ª 48160 Derio / ES | [2023/23] | Inventor(s) | 01 /
FERNÁNDEZ-TEJADA, Alberto 48160 Derio, Vizcaya / ES | 02 /
PIFFERI, Carlo 48160 Derio, Vizcaya / ES | 03 /
FUENTES GARCÍA, Roberto 48160 Derio, Vizcaya / ES | 04 /
ANGUITA CASTILLO, Juan 48160 Derio, Vizcaya / ES | [2023/23] | Representative(s) | ABG Intellectual Property Law, S.L. Avenida de Burgos, 16D Edificio Euromor 28036 Madrid / ES | [2023/23] | Application number, filing date | 21383098.7 | 03.12.2021 | [2023/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4190359 | Date: | 07.06.2023 | Language: | EN | [2023/23] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 23.06.2022 | Classification | IPC: | A61K47/55, A61K47/64, A61K39/39, A61K39/385, A61K39/00, C07H15/256, C07J51/00, A61P25/28, A61P31/00, A61P35/00 | [2023/23] | CPC: |
A61K47/55 (EP);
A61K39/00117 (EP);
A61K39/385 (EP);
A61K39/39 (EP);
A61K47/6425 (EP);
A61K47/646 (EP);
A61P25/28 (EP);
A61P31/00 (EP);
A61P35/00 (EP);
C07H15/256 (EP);
C07J63/008 (EP);
C07K14/005 (EP);
C07K14/22 (EP);
C07K14/33 (EP);
C07K14/445 (EP);
C07K14/4748 (EP);
C07K14/705 (EP);
C07K7/08 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/23] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | SAPONINBASIERTE ADJUVANTIEN UND IMPFSTOFFE | [2023/23] | English: | SAPONIN-BASED ADJUVANTS AND VACCINES | [2023/23] | French: | ADJUVANTS ET VACCINS À BASE DE SAPONINE | [2023/23] | Examination procedure | 08.12.2023 | Application deemed to be withdrawn, date of legal effect [2024/19] | 05.01.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2024/19] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.12.2023 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US5583112 (KENSIL CHARLOTTE A [US], et al) [A] 1-14 * column 9, line 4 - column 11, line 5 ** examples 18-21, 23, 24 *; | [A] - ALBERTO FERNÁNDEZ-TEJADA ET AL, "Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol", BIOORGANIC, AMSTERDAM, NL, (20140917), vol. 22, no. 21, doi:10.1016/j.bmc.2014.09.016, ISSN 0968-0896, pages 5917 - 5923, XP055423243 [A] 1-14 * abstract * * figures 1-4 * * page 5921, column 1, paragraph 3 - column 2, paragraph 1 * DOI: http://dx.doi.org/10.1016/j.bmc.2014.09.016 | by applicant | WO2009126737 | WO2015184451 | WO2017079582 | WO2017106836 | WO2018191598 | WO2018200645 | WO2018200656 | WO2019079160 | - PIFFERI, C.FUENTES, R.FERNANDEZ-TEJADA, A., "Natural and Synthetic Carbohydrate-Based Vaccine Adjuvants and Their Mechanisms of Action", Nat. Rev. Chem., vol. 25, no. 4, (20210000), pages 3 - 7, URL: https://doi.orq/10.1038/s41570-020-00244-3 | - BERGMANN-LEITNER, E.LEITNER, W., "Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators", Vaccines, vol. 2, no. 2, (20140000), pages 252 - 296, URL: https://doi.org/10.3390/vaccines2020252 | - REED, S. G.ORR, M. T.FOX, C. B., "Key Roles of Adjuvants in Modern Vaccines", Nat. Med., vol. 19, no. 12, doi:10.1038/nm.3409, (20130000), pages 1597 - 1608, URL: https://doi.orQ/10.1038/nm.3409, XP037135483 DOI: http://dx.doi.org/10.1038/nm.3409 | - J. Pharmaceutical Sciences, (19770000), vol. 66, pages 1 - 19 | - SMALL, HANDBOOK OF LIPID RESEARCH, Plenum, (19860000), vol. 4, pages 49 - 50 | - AHMAD, T. A. et al., Trials in Vaccinology, vol. 5, (20160000), pages 71 - 83, URL: https://doi.or/10.1016/i.trivac.2016.04.003 | - WANG R. F., Methods, (20030000), vol. 29, no. 3, pages 227 - 35 | - SINGH R. et al., Immunology, (20140000), vol. 141, no. 4, pages 514 - 30 | - RECHE et al., Immunogenetics, (20040000), vol. 56, no. 6, pages 405 - 419 | - DONNESKOHLBACHER, Protein Sci., (20050000), vol. 14, no. 8, pages 2132 - 2140 | - DOYTCHINOVA et al., MC Bioinformatics, (20060000), vol. 7, no. 1, page 131 | - ERICKSON et al., J. Immunol., (19930000), vol. 151, pages 4189 - 4199 | - DOE et al., Eur. J. Immunol., (19940000), vol. 24, pages 2369 - 2376 | - GHIRARDELLO, M.RUIZ-DE-ANGULO, A.SACRISTAN, N.BARRIALES, D.JIMENEZ-BARBERO, J.POVEDA, A.CORZANA, F.ANGUITA, J.FERNANDEZ-TEJADA, A., "Exploiting Structure-activity Relationships of QS-21 in the Design and Synthesis of Streamlined Saponin Vaccine Adjuvants", Chem. Commun., vol. 56, no. 5, doi:10.1039/C9CC07781B, (20200000), pages 719 - 722, URL: https://doi.org/10.1039/C9CC07781B., XP055755364 DOI: http://dx.doi.org/10.1039/C9CC07781B | - PAYNE, R. J.FICHT, S.TANG, S.BRIK, A.YANG, Y. Y.CASE, D. A.WONG, C. H., "Extended Sugar-Assisted Glycopeptide Ligations: Development, Scope, and Applications", J. Am. Chem. Soc., vol. 129, no. 44, (20070000), pages 13527 - 13536, URL: https://doi.ora/10.1021/ia073653p, XP009136144 | - WU, Z.GUO, X.GUO, Z., "Chemoenzymatic Synthesis of Glycosylphosphatidylinositol-Anchored Glycopeptides", Chem. Commun., vol. 46, no. 31, (20100000), pages 5773 - 5774, URL: https://doi.org/10.1039/C0CC00828A | - WITTMANN, V.TAKAYAMA, S.GONG, K. W.WEITZ-SCHMIDT, G.WONG, C. H., "Ligand Recognition by E- and P-Selectin: Chemoenzymatic Synthesis and Inhibitory Activity of Bivalent Sialyl Lewis x Derivatives and Sialyl Lewis x Carboxylic Acids", J. Org. Chem., vol. 63, no. 15, (19980000), pages 5137 - 5143, URL: https://doi.org/10.1021/io980350s | - FERNANDEZ-TEJADA, A.CHEA, E. K.GEORGE, C.PILLARSETTY, N.GARDNER, J. R.LIVINGSTON, P. O.RAGUPATHI, G.LEWIS, J. S.TAN, D. S.GIN, D. Y., "Development of a Minimal Saponin Vaccine Adjuvant Based on QS-21", Nat. Chem., vol. 6, no. 7, doi:10.1038/nchem.1963, (20140000), pages 635 - 643, URL: https://doi.org/10.1038/nchem.1963, XP055561598 DOI: http://dx.doi.org/10.1038/nchem.1963 | - T. BUSKAS et al., Angew. Chem., (20050000), vol. 44, pages 5985 - 5988 | - BUSKAS, T.INGALE, S.BOONS, G.-J., "Towards a Fully Synthetic Carbohydrate-Based Anticancer Vaccine: Synthesis and Immunological Evaluation of a Lipidated Glycopeptide Containing the Tumor-Associated Tn Antigen", Angew. Chemie, vol. 44, no. 37, doi:10.1002/anie.200501818, (20050000), pages 5985 - 5988, URL: https://doi.org/10.1002/anie.2005Q1818, XP002456422 DOI: http://dx.doi.org/10.1002/anie.200501818 | - DOE, B.STEIMER, K.S.WALKER, C.M., "Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans", Eur J Immunol., vol. 24, no. 10, doi:10.1002/eji.1830241017, (19941000), pages 2369 - 76, URL: https://doi.or/10.1002/eii.1830241017, XP002910683 DOI: http://dx.doi.org/10.1002/eji.1830241017 | - DONNES, P.KOHLBACHER, O., "Integrated modeling of the major events in the MHC class I antigen processing pathway", Protein Sci, vol. 14, no. 8, (20050800), pages 2132 - 40, URL: https://doi.or/10.1110/ps.051352405 | - DOYTCHINOVA, I.A.GUAN, P.FLOWER, D.R., "EpiJen: a server for multistep T cell epitope prediction", BMC Bioinformatics, vol. 7, doi:10.1186/1471-2105-7-131, (20060313), page 131, URL: https://doi.org/10.1186/1471-2105-7-131, XP021013634 DOI: http://dx.doi.org/10.1186/1471-2105-7-131 | - ERICKSON, A.L.HOUGHTON, M.CHOO, Q.L.WEINER, A.J.RALSTON, R.MUCHMORE, E.WALKER, C.M., "Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C", J Immunol., (19931015), vol. 151, no. 8, pages 4189 - 99, XP001026213 | - RECHE, P. A.GLUTTING, J. P.ZHANG, H.REINHERZ, E.L., "Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles", Immunogenetics, vol. 56, no. 6, doi:10.1007/s00251-004-0709-7, (20040900), pages 405 - 19, URL: https://doi.orQ/10.1007/s00251-004-0709-7, XP055560187 DOI: http://dx.doi.org/10.1007/s00251-004-0709-7 | - SINGH R.GUPTA P.SHARMA P. K.ADES E. W.HOLLINGSHEAD S. K.SINGH S.LILLARD J. W., "Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A", Immunology, vol. 141, no. 4, (20140400), pages 514 - 30, URL: https://doi.orQ/10.1111/imm.12194 | - WANG R. F., "Identification of MHC class II-restricted tumor antigens recognized by CD4+ T cells", Methods, vol. 29, no. 3, doi:10.1016/S1046-2023(02)00345-6, (20030300), pages 227 - 35, URL: https://doi.orQ/10.1016/s1046-2023(02)00345-6, XP002319744 DOI: http://dx.doi.org/10.1016/S1046-2023(02)00345-6 |